|
|
Nutritional status assessment for patients with common cancer in a hospital of Chongqing |
1, 2HE Ying, 1LIN Xin, 2LIU Li, 1WANG Jia-jia, 3SONG Chun-hua, 4SHI Han-ping, 1XU Hong-xia, Investigation on Nutrition Status and its Clinical Outcome of Common Cancers (INSCOC) Group |
1Department of Nutrition, Daping Hospital & Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China; 2Department of Nutrition, Chongqing General Hospital, Chongqing 400014, China; 3Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou 450001, China; 4Department of General Surgery, Aviation General Hospital/Beijing Institute of Translational Medicine, Chinese Academy of Sciences, Beijing 100012, China |
|
|
Abstract Objective To investigate the nutritional status of hospitalized patients with common malignant tumor in Chongqing General Hospital. Methods From May 4th 2015 to Dec 31st 2015, we enrolled 311 patients with cancer hospitalized for treatment in Chongqing General Hospital. These patients were diagnosed with one of the following 16 different types of malignant tumors: lung cancer, gastric cancer, liver cancer, colorectal cancer, breast cancer, esophageal cancer, cervical cancer, endometrial cancer, nasopharyngeal carcinoma, malignant lymphoma, leukemia, pancreatic cancer, ovarian cancer, prostate cancer, bladder cancer and brain tumor. Nutritional risk screening 2002 (NRS 2002), patient-generated subjective global assessment (PG-SGA), anthropometric measurements, and laboratory examination were used to evaluate the nutritional risk or nutritional status. We also investigated the nutritional therapy of these cancer patients. Results According to the NRS 2002 score, 138 patients (44.37%) had the nutritional risk (score≥3); With PG-SGA score as standard, 52.73% (164/311)of the cancer patients were malnutrition (PG-SGA≥4), and 31.19% (97/311) were severe malnutrition (PG-SGA≥9). The rate of malnutrition for gastrointestinal cancer patients is higher than Nongastrointestinal cancer patients (65.41% vs. 43.26%, χ2=13.417, P<0.001). Multiple linear regression analysis, PG-SGA scores and body mass index (P<0.001), serum albumin (P<0.001), prealbumin (P<0.001), the percentage of weight loss in the recent 1 month(P<0.001), calf circumference (left side, P=0.001),non-profit grip strength (P=0.001) were correlated, in which left calf circumference, last 1 month weight loss percentage correlation with PG-SGA scoring the best (regression coefficient b-0.872, 0.861, P<0.001, respectively), hemoglobin, arm muscle circumference and PG-SGA scores correlated without statistical significance (P, 0.268, 0.218, respectively); 43.90% (72/164) of all the moderately and severely malnourished patients received nutritional therapy, 91.7% (66/72) were receive only parenteral nutrition, 6.94% (5/72) were received enteral and parenteral nutrition, just one case (1.38%, 1/72) were received only enteral nutrition. Conclusions 52.73% of the common malignant tumor patients enrolled in the present study were malnutrition. PG-SGA is an effective tool to assess malnutrition in cancer patients, it is recommended to conduct routine assessment of cancer patients at the beginning of admission. Nutritional therapy of malignant tumor patients with malnutrition is very low, especially enteral nutritional support. Suggestions for patients with malignant tumor after admission nutritional risk screening, and comprehensive nutritional evaluation, including PG-SGA score, and to give the right nutritional therapy.
|
|
|
|
|
[1] |
WANG Chao-yun, DU Cheng, GUAN Xin, DU Xiao-wei, XU Zhu-xuan, ZHENG Zhen-dong. Advances in drug therapy for cancer cachexia[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 382-385. |
[2] |
1FAN Yue-ping, 2ZHANG Tian, 2QU Qian-nuo, 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
[3] |
1XUE Tao, 1WANG Wei-hong, 2MA Hui,1ZHANG Na,1ZHANG Sheng-Jun, 1DU Xin-ying . Application of perioperative nutritional support in patients with meningioma[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 326-331. |
[4] |
1*LUO Min, 2*WU Xiao-jun, 2ZHANG Xin, 3DONG Guang, 4XIONG Li-long, 4WANG Peng-cheng, 1GAO Kui, 1YU Ping, 1HE Mei, 5DU Chi, 5JIANG Ou, 6SHI Han-ping . ABD bioactives alleviates chemotherapy-induced myelosuppression[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 346-350. |
[5] |
SHENG Xiang, LI Su-yi. Advances in research on intestinal microecology and clinical outcomes of tumors[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 178-182. |
[6] |
GAO Chun, LI Meng, WEI Jun-min, LI Yu-zhen, TIAN Wei-jun, JIANG Hai-ping, SHEN Wei, XU Ai-guo, YU Zhen, CHEN Dong-sheng, CHEN Lian-zhen, GUAN Wen-xian, JIANG Hua, LI Da-kui, MEI Dan, YU Ji-ren, ZHAO C. Expert consensus on clinical use of compound amino acid injection[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 183-189. |
|
|
|
|